Decreased levels of TNF- and IL-6 indicate that NNMT inhibition not only modulates metabolism but also improves the inflammatory microenvironment, a key component in metabolic disease development and insulin resistance
This comprehensive analysis examines the clinical trial evidence for AOD-9604s safety profile, including participant numbers, study designs, reported adverse effects, metabolic safety markers, immunogenicity data, and how this peptides safety characteristics compare to related therapies
How AOD-9604 Works AOD-9604 is a modified fragment of human growth hormone derived from amino acids 176-191 of the HGH molecule
Selective NNMT inhibition as a strategy for metabolic disease
This surge in cellular energy translates into tangible benefits heightened focus, increased endurance, and a vitality boost